Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroquel XR in the Long Term Treatment of Schizophrenia Focus on Affective Symptoms

NCT01202617 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01202617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01202617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroquel XR in the Long Term Treatment of Schizophrenia Focus on Affective Symptoms
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
October 31, 2011
Enrollment
1,606 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

relapse in schizophrenia